Cipla Limited
NSE: CIPLA | Information Technology
Market Fundamentals
Stock Intelligence & News
Cipla Ltd (500087)
Please find attached disclosure on ESG Ratings.
Read Full Analysis →Cipla Ltd (500087)
Please find enclosed intimation.
Read Full Analysis →Cipla Limited
Update on USFDA inspection at InvaGen manufacturing facility in Hauppauge, Long Island, New York, USA |SUBJECT: General Updates
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Cipla's US Milestone Gets The Street Talking. Analysts See Bigger Opportunity Ahead
Cipla In Focus
Read Full Analysis →US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipeline
Indian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy's and Cipla saw significant drops in their net profits and operating margins. However, their domestic businesses continued to perform well, offering a positive outlook. Obesity therapies and specialty product launches are expected to drive future growth for these companies. Analysts have consequently reduced earnings forecasts for the upcoming fiscal years.
Read Full Analysis →Cipla shares rise 3.7% despite Q1 profit fall, brokerages remain cautious
The company’s Q1 PAT decreased to ₹789 crore from ₹1,298 crore last year, while total revenue rose to ₹7,119 crore from ₹6,957 crore
Read Full Analysis →Cipla Q1 results: Profit falls 39% YoY to ₹789.05 crore
Cipla Q1 results: Profit falls 39% YoY to ₹789.05 crore
Read Full Analysis →Cipla Shares Fall 2% After Q1 Profit Declines Nearly 40%
Cipla shares fell 2% during the trading session on Thursday, July 22 after the pharma company announced first quarter results for the fiscal 2027, reporting a 39% drop in net profit.
Read Full Analysis →Cipla Q1 Results: Profit Falls 39%, Misses Estimates, Margin Contracts
The drugmaker's June-quarter profit and operating margin missed analyst estimates, while revenue was broadly in line with expectations.
Read Full Analysis →Get instant alerts when CIPLA breaks news
Join investors who track Cipla Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for CIPLA?
CIPLA is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Cipla Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding CIPLA to your custom watchlist.